相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。mTOR inhibitors and dyslipidemia in transplant recipients: A cause for concern?
Hallvard Holdaas et al.
TRANSPLANTATION REVIEWS (2015)
AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation
Elisa Boscolo et al.
ANGIOGENESIS (2015)
Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration
Inho Choi et al.
ANGIOGENESIS (2013)
The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
Adam L. Hartman et al.
PLOS ONE (2012)
The New Era of the Lymphatic System: No Longer Secondary to the Blood Vascular System
Inho Choi et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The integral role of mTOR in lipid metabolism
Ghada A. Soliman
CELL CYCLE (2011)
Genomic Convergence among ERRα, PROX1, and BMAL1 in the Control of Metabolic Clock Outputs
Catherine R. Dufour et al.
PLOS GENETICS (2011)
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Vanessa P. Houde et al.
DIABETES (2010)
The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions
Alexis Charest-Marcotte et al.
GENES & DEVELOPMENT (2010)
Heterogeneity and Plasticity of Lymphatic Endothelial Cells
Sunju Lee et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate
Sunju Lee et al.
BLOOD (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Prospero-related homeobox 1 (Prox1) is a stable hepatocyte marker during liver development, injury and regeneration, and is absent from oval cells
Jozsef Dudas et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2006)
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
Dimple Aggarwal et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
A prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4α that regulates the cholesterol 7α-hydroxylase gene
KH Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity
NL Harvey et al.
NATURE GENETICS (2005)
Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
BD Kahan et al.
TRANSPLANTATION (2005)
Prospero-related homeobox (Prox1) is a corepressor of human liver receptor homolog-1 and suppresses the transcription of the cholesterol 7-α-hydroxylase gene
J Qin et al.
MOLECULAR ENDOCRINOLOGY (2004)
TOR signalling in bugs, brain and brawn
E Jacinto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Effects of sirolimus on lipids in renal allograft recipients: An analysis using the Framingham risk model
CB Blum
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
The limitations of calcineurin and mTOR inhibitors: New directions for immunosuppressive strategies
BD Kahan
TRANSPLANTATION PROCEEDINGS (2002)
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
M Hidalgo et al.
ONCOGENE (2000)
分享论文
